Leaderboard

En | De
Sie sind hier: Onkologie » Gynäkologische Tumoren 21. Juli 2026
Suchen
medline.ch
Gynäkologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 16623  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 332454  
   
Patient Portal Use and Cancer Screening in the United States: Individual Associations and Population Impact.
J Prim Care Community Health
Ejaz R, Chatzipanagiotou OP, Alizai Q, Sarfraz A, Charalampous CM, Elemosho A, Bega R, Pawlik TM.
PMID: 42478347 [PubMed - indexed for MEDLINE]


Brazilian Society of Surgical Oncology Analysis in Cost-Effectiveness of Population-Based BRCA Testing for Ovarian Cancer in the Public Health System.
J Surg Oncol
Oliveira AF, de Santa Rosa AAP, Tsunoda AT, Azevedo BRB, de Carvalho EM, Baiocchi G, Lyra JS, de Sousa Fernandes PH, Zanatto RM, Ribeiro R, da Costa Vieira RA, de Lorena Medeiros RC, Pinheiro RN, Reis RJ, Carneiro VCG, Oliveira VRE.
PMID: 42478334 [PubMed - as supplied by publisher]


Expression Levels of DNMT1, HDAC1, and MT1E Genes as Diagnostic Biomarkers for Breast Cancer Clinicopathological Features: In Vitro and In Silico Analyses.
Anal Cell Pathol (Amst)
Akhtartavan S, Madanchi H, Ghorbani R, Khalafi-Nezhad A, Abdullahi A, Shamsi F, Heli H.
PMID: 42478333 [PubMed - indexed for MEDLINE]


Safety evaluation of bleomycin in ovarian cancer treatment: A pharmacovigilance analysis using Food and Drug Administration adverse event reporting system data.
J Int Med Res
Zhou X, Wang X, Su L, Hao Y.
PMID: 42478093 [PubMed - indexed for MEDLINE]


Clinical outcomes of sacituzumab govitecan in older patients with metastatic triple-negative breast cancer: a multinational real-world study.
Oncologist
Konieczna A, Pieni, , Polakiewicz-Gilowska A, Soumarová R, Holánek M, , M, Winsko-Szcz, Lisik-Habib M, P, Krej, , Kolá, Danielewicz I, Szymanik-Resko M, Ciszewski T, Ru, Czartoryska-Ar, , Jarz, Kubeczko M, Pacholczak-Madej R, Smok-Kalwat J, Nowecki Z, Biel, Malej, Püsküllüo.
PMID: 42477865 [PubMed - as supplied by publisher]


Oncological outcome of endoscopic nipple-sparing mastectomy versus conventional open mastectomy in early breast cancer: a multicenter cohort study.
World J Surg Oncol
Zhu L, Ye X, Zhang Z, Fang Y, Liu D, Ding S, Zhu Y, Wang Q, Wang W, Wang M.
PMID: 42477801 [PubMed - as supplied by publisher]


CK2 in triple-negative breast cancer: oncogenic signaling networks and emerging CK2 inhibitor-based combination therapies.
Clin Exp Med
Ellyan NS, Alex AT, Nayak UY, Raj A, K R.
PMID: 42477293 [PubMed - as supplied by publisher]


Reproductive concerns and quality of life among Chinese women undergoing fertility-sparing surgery for gynecologic malignancies: a mixed-methods study.
Support Care Cancer
Shen Y, Jiang C, Jiang Y, Lai Y.
PMID: 42477276 [PubMed - indexed for MEDLINE]


The WinPro trial: window-of-opportunity study of endocrine therapy with micronised progesterone in ER-positive breast cancer.
NPJ Breast Cancer
Haggstrom L, Middleton K, Parker A, Segara D, Ong A, Bingham J, Carson EK, Kiely BE, Sabanathan D, Spillane A, Saw K, Serrano A, Lindeman GJ, Swarbrick A, Coates A, Mann GB, Tilley W, Lim E.
PMID: 42477003 [PubMed - as supplied by publisher]


Effectiveness of Decision Aids for Breast Cancer Treatment: A Systematic Review and Meta-Analysis.
Cancer Nurs
Hua Y, Huang Y, Han Y, Chow KM, Yu X, Su X, Qiu A, Zhu J.
PMID: 42476578 [PubMed - as supplied by publisher]


Online sexual health interventions for breast cancer survivors: a systematic review of program features and sexual outcomes.
Sex Med Rev
Bagheri B, Moghaddam-Banaem L, Ali Azin S, Safaei AA, Haghighat S.
PMID: 42476542 [PubMed - indexed for MEDLINE]


A new chapter in precision medicine: Circulating tumor cells in breast cancer prognosis and treatment.
Biochim Biophys Acta Rev Cancer
Li C, Chen M, Wang Z, Wang X, Jin H.
PMID: 42476386 [PubMed - as supplied by publisher]


Molecular Mechanisms of Targeted Therapy in Breast Cancer: An Integrated Signaling Network Perspective.
Crit Rev Oncol Hematol
Wang Y, Zhang M, Zhang X, Guo T, Wang Y, Yu C.
PMID: 42476234 [PubMed - as supplied by publisher]


Autophagy potential of polyphenols in breast carcinoma: A systematic review.
Pathol Res Pract
Golchin A, Teymori Nobari S, Maleki M, Yazdani M, Yousefi B.
PMID: 42475944 [PubMed - as supplied by publisher]


Cardiovascular versus breast cancer mortality in men with breast cancer: An age-stratified SEER competing-risk study.
Biomol Biomed
Zihni , Zihni B, Sabuncuo.
PMID: 42475476 [PubMed - as supplied by publisher]


The incidence and risk factors of sepsis following ovarian cancer surgery: A retrospective Nationwide Inpatient Sample database study.
PLoS One
Wang Y, Zheng J, Lv Q, Xu GM, Xie H, Dong BF, Wang X.
PMID: 42475320 [PubMed - indexed for MEDLINE]


Digital Mental Health Treatment and Symptoms of Depression and Anxiety in Breast Cancer Survivors: A Randomized Clinical Trial.
JAMA Netw Open
Chow PI, You W, Shaffer KM, Cohn WF, Showalter SL, Orange C, Ritterband LM, Mohr DC.
PMID: 42475097 [PubMed - indexed for MEDLINE]


Real-world treatment patterns and outcomes in hormone receptor-positive, HER2-low metastatic breast cancer, 2018-2023: a retrospective, observational, US cohort study.
Breast Cancer Res Treat
Mayer EL, Collin SM, Hillman S, Berrocal-Almanza LC, Sparano J, Lam C.
PMID: 42474828 [PubMed - indexed for MEDLINE]


Clinical and molecular features of resected breast cancer brain metastases: a single center retrospective cohort study.
Breast Cancer Res Treat
Krasnow NA, Salans M, Jayaraj M, Kuwahara K, Zhou MH, Boreta L, Braunstein SE, Aghi MK, Chien J, Rugo H, Melisko ME, Morshed RA, Vasudevan HN, Huppert LA.
PMID: 42474755 [PubMed - indexed for MEDLINE]


Factors influencing discussion duration in breast cancer multidisciplinary team meetings: insights for streamlining care.
Breast Cancer Res Treat
Ko, Sanderink WBG, Prokop M, Mann RM.
PMID: 42474586 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 332454    Seite 1 von 16623  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1